Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis

被引:113
作者
Breuer, RHJ
Snijders, PJF
Smit, EF
Sutedja, TG
Sewalt, RGAB
Otte, AP
van Kemenade, FJ
Postmus, PE
Meijer, CJLM
Raaphorst, FM
机构
[1] VU Med Ctr, Dept Pathol, Amsterdam, Netherlands
[2] VU Med Ctr, Dept Pulmonol, Amsterdam, Netherlands
[3] Univ Amsterdam, Swammerdam Inst Life Sci, BioCentrum Amsterdam, Amsterdam, Netherlands
来源
NEOPLASIA | 2004年 / 6卷 / 06期
关键词
premalignant lesions; BMI-1; EZH2; polycomb genes; lung carcinoma;
D O I
10.1593/neo.04160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polycomb group (PcG) genes are responsible for maintenance of cellular identity and contribute to regulation of the cell cycle. Recent studies have identified several PcG genes as oncogenes, and a role for PcG proteins in human oncogenesis is suspected. We investigated the expression of BMI-1 and EZH2 PcG oncogenes in human bronchial squamous cell carcinomas (SCCs) and bronchial premalignant precursor lesions (PLs). Whereas normal bronchial epithelium was associated with widespread expression of BMI-1 in resting EZH2-negative cells, neoplastic cells in lung carcinomas displayed altered expression of both BMI-1 and EZH2. Two patterns of abnormal PcG expression were observed: increased expression of BMI-1 in dividing neoplastic cells of PLs and SCCs, and enhanced expression of EZH2 and Ki-67 in BMI-1-positive cells according to severity of the histopathologic stage. We propose that altered expression of BMI-1 and EZH2 is an early event that precedes high rates of proliferation in lung cancer. Because PcG complexes are normally involved in the maintenance of cell characteristics, abnormal PcG expression may contribute to loss of cell identity.
引用
收藏
页码:736 / 743
页数:8
相关论文
共 51 条
  • [1] Perturbation of B and T cell development and predisposition to lymphomagenesis in E mu Bmi1 transgenic mice require the Bmi1 RING finger
    Alkema, MJ
    Jacobs, H
    vanLohuizen, M
    Berns, A
    [J]. ONCOGENE, 1997, 15 (08) : 899 - 910
  • [2] Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian Polycomb complex
    Alkema, MJ
    Bronk, M
    Verhoeven, E
    Otte, A
    vantVeer, LT
    Berns, A
    vanLohuizen, M
    [J]. GENES & DEVELOPMENT, 1997, 11 (02) : 226 - 240
  • [3] HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and Has transcriptional repression properties
    Bárdos, JI
    Saurin, AJ
    Tissot, C
    Duprez, E
    Freemont, PS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) : 28785 - 28792
  • [4] EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
    Adrian P. Bracken
    Diego Pasini
    Maria Capra
    Elena Prosperini
    Elena Colli
    Kristian Helin
    [J]. The EMBO Journal, 2003, 22 (20) : 5323 - 5335
  • [5] Cell memory and cancer -: the story of the trithorax and Polycomb group genes
    Caldas, C
    Aparicio, S
    [J]. CANCER AND METASTASIS REVIEWS, 1999, 18 (02) : 313 - 329
  • [6] Role of histone H3 lysine 27 methylation in polycomb-group silencing
    Cao, R
    Wang, LJ
    Wang, HB
    Xia, L
    Erdjument-Bromage, H
    Tempst, P
    Jones, RS
    Zhang, Y
    [J]. SCIENCE, 2002, 298 (5595) : 1039 - 1043
  • [7] Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites
    Czermin, B
    Melfi, R
    McCabe, D
    Seitz, V
    Imhof, A
    Pirrotta, V
    [J]. CELL, 2002, 111 (02) : 185 - 196
  • [8] Dimri GP, 2002, CANCER RES, V62, P4736
  • [9] Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines
    Dukers, DF
    van Galen, JC
    Giroth, C
    Jansen, P
    Sewalt, RGAB
    Otte, AP
    Kluin-Nelemans, HC
    Meijer, CJLM
    Raaphorst, FM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (03) : 873 - 881
  • [10] Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus
    Ferreux, E
    Lont, AP
    Horenblas, S
    Gallee, MPW
    Raaphorst, FM
    Doeberitz, MV
    Meijer, CJLM
    Snijders, PJF
    [J]. JOURNAL OF PATHOLOGY, 2003, 201 (01) : 109 - 118